ArticleJournal of gastrointestinal cancer2026

Post-neoadjuvant Metabolic Response Assessed by ¹⁸F-FDG PET/CT Predicts Pathologic Complete Response and Survival in Esophageal Squamous Cell Carcinoma Treated with the CROSS Regimen.

Saravanan Moorthy et al.PubMed ↗Publisher ↗

No numbers read from the abstract.